Find-A-Study

A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with non-diabetic chronic kidney disease

Purpose

Category

Urinary Tract and Kidney

IRB Number: 20210618HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Principal Investigator
Shweta Bansal

Shweta Bansal
2100-567-5338
bansals3@uthscsa.edu

Aliseiya Garza
(210) 567-4700
garzaa35@uthscsa.edu

Myriam Gonzalez
(210) 562-6516
gonzalezm38@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups